Skip to content
Luna Metabolic
Menu

Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.

Head-to-head for women

Eden vs SkinnyRx

Eden and SkinnyRx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Eden

Higher score

Ranked #3 for women · Grade B+

Best for: Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency.

FDA warning letterJune 2026Read it ↗Visit Eden
vs

SkinnyRx

Ranked #56 for women · Grade C

Best for: Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one.

FDA warning letterFebruary 2026Read it ↗Visit SkinnyRx

The verdict for women

Higher Luna Fit Score: Eden

Eden edges out SkinnyRx on the Luna Fit Score, 88 to 71 (B+ vs C). Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency. The reasoning behind that number is in our Eden write-up for women.

SkinnyRx is still a genuine option — the rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you. Weigh the six women's-health factors below against your own priorities; the SkinnyRx scorecard goes through each of them, and if neither of these two is the one, our ranked shortlist of SkinnyRx alternatives widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Eden SkinnyRx
PCOS & hormonal suitability8974
Eden
SkinnyRx
Clinical oversight & labs8167
Eden
SkinnyRx
Price transparency8862
Eden
SkinnyRx
Nationwide access9582
Eden
SkinnyRx
Ongoing support9184
Eden
SkinnyRx
Cancellation fairness8958
Eden
SkinnyRx

Price, access & features

DetailEdenSkinnyRx
Luna Fit Score88/100 · B+71/100 · C
Overall rank#3#56
Semaglutide$239/mo$349/mo month-to-month (from $199/mo on a 12-month plan) — the site displays only the 12-month rate
Tirzepatide$349/mo$399/mo month-to-month, injectable or dissolving tablet (from $299/mo on a 12-month plan) — the site displays only the 12-month rate
CoverageAll 50 statesNo state list published; the offer terms report no state restrictions
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

Eden

Ranked #3 · Grade B+

What we like

  • Clear clinician and supply-chain disclosure — among the most transparent in the ranking about who and what is behind the prescription
  • Nationwide availability with both molecules
  • High verification confidence: the facts it publishes hold up when checked

The caveats

  • Premium pricing versus the cheapest tiers
  • Compounded only — no brand-name access
  • Not a hormone-specialty clinic; PCOS framing is general

SkinnyRx

Ranked #56 · Grade C

What we like

  • A compounded tirzepatide TABLET — a dissolving sublingual route for the dual GIP/GLP-1 molecule, priced identically to the injection at every rung, which is close to unique in this ranking
  • Both molecules across three routes — injection, sublingual and daily tablet — so needle aversion never means changing provider or dropping back to the single-pathway drug
  • Lower-dose "microdose" lines for both molecules are sold as their own products with their own published ladders, rather than being quoted at the full-dose price

The caveats

  • Carries an active FDA warning letter issued in February 2026 (see the notice on this page for FDA's own record)
  • Every price the site advertises is the TWELVE-MONTH rung: its own headline reads "Starting at $299/mo" while the month-to-month tirzepatide rate is $399 and the renewal price in its code is literally 399 — semaglutide is the same shape at $199 advertised against $349 month-to-month
  • The commitment is not named beside the number anywhere in the marketing copy, and the prepay rung is also what its schema.org product markup publishes as the price — so search engines and AI assistants are given the twelve-month rate as though it were the monthly one

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Eden nor SkinnyRx is only worth comparing with the other. Eden is also written up against Ondra Health, an exact tie on the Luna Fit Score — see the Eden–Ondra Health head-to-head. SkinnyRx is also written up against CoreAge Rx, 22 points apart — see the SkinnyRx–CoreAge Rx head-to-head.

Or browse the full comparison hub.